Dr. Tuchman spends half of his time caring for patients with multiple myeloma and other plasma cell disorders, and the other half of his time performing clinical research. His specific research interests include 1) investigating therapeutic approaches for patients who are vulnerable to toxicity from therapy due to advanced age or other medical problems, 2) novel therapies including immunotherapies such as chimeric antigen receptor – T cells (CAR-T), and 3) therapeutic approaches to rarer myeloma-related conditions such as amyloidosis. Dr. Tuchman is an active member of expert groups such as the International Myeloma Working Group, his work has been supported by NIH, foundation and industry grants, and he is widely published in leading oncology and hematology journals.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811